NF 22 µg y 44µg


Download pdf


Each prefilled syringe of Inmunomas NF 22 contains 22 mcg (6 MIU) of recombinant human interferon beta-1a (IFN beta 1a-r- hu) / 0.5 ml. Each prefilled syringe of Inmunomas NF 44 contains 44 mcg (12 MIU) recombinant human interferon beta-1a (IFN beta1a-r- hu) / 0.5 ml.

Mechanism of Action



Treatment for patients with relapsing-remitting multiple sclerosis (RRMS) capable of walking that have experienced at least 2 recurrent neurological dysfunction episodes or flare-ups (relapses) within the two previous years.

Dosage and Administration

16 and older: 1 prefilled syringe of Inmunomas NF 44 three times a week for subcutaneous injection. For patients who may not tolerate the higher dose, administer Inmunomas 22 also three times a week via subcutaneous injection.

Package Size

Inmunomas NF 22 and 44: 12 prefilled ready-to-use syringes with needles.

Exclusive content for Professionals

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
New User Registration
*Required field